AZD3199
/ AstraZeneca
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 04, 2011
Evaluation of the pharmacokinetics and the pharmacodynamics of different dry powder inhalation formulations of AZD3199 in patients with asthma
(clinicaltrials.gov)
- P2, N=24; Not yet recruiting
Asthma
1 to 1
Of
1
Go to page
1